|
Volumn 31, Issue 8, 2001, Pages 357-358
|
Cancer chemoprevention as adjuvant therapy for hepatocellular carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
IODINATED POPPYSEED OIL;
IODINE 131;
PLACEBO;
POLYPRENOIC ACID;
RETINOID DERIVATIVE;
TUMOR MARKER;
APOPTOSIS;
CANCER ADJUVANT THERAPY;
CANCER CONTROL;
CANCER DIAGNOSIS;
CANCER IMMUNOTHERAPY;
CANCER INVASION;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER SCREENING;
CANCER SURGERY;
CANCER SURVIVAL;
CHEILITIS;
CHEMOPROPHYLAXIS;
CHRONIC LIVER DISEASE;
CLINICAL TRIAL;
CONJUNCTIVITIS;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC IMAGING;
DRUG EFFECT;
DRY SKIN;
EARLY DIAGNOSIS;
EDITORIAL;
FOLLOW UP;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
JAPAN;
LIVER CARCINOGENESIS;
LIVER CELL CARCINOMA;
LONG TERM CARE;
METASTASIS;
PROGNOSIS;
RECURRENCE RISK;
RISK BENEFIT ANALYSIS;
SEX DIFFERENCE;
TREATMENT OUTCOME;
TUMOR DIFFERENTIATION;
|
EID: 0034787495
PISSN: 03682811
EISSN: None
Source Type: Journal
DOI: 10.1093/jjco/hye081 Document Type: Editorial |
Times cited : (7)
|
References (14)
|